Core Viewpoint - The insurance sector is actively increasing its equity asset allocation, with significant potential for future growth in this area [1][4]. Group 1: Insurance Companies' Activities - China Pacific Life Insurance Co., Ltd. announced its recent acquisition of shares in Guangdong Dongyangguang Pharmaceutical Co., Ltd., holding approximately 605.86 million shares, which represents 5.38% of the latter's H-share capital [2]. - As of August 13, 2023, the total number of equity stakes acquired by insurance capital reached 27 this year, significantly higher than the 20 instances recorded in the previous year [2]. - The majority of these acquisitions were driven by proactive buying, indicating a strong willingness among insurance companies to increase their holdings in listed companies [2]. Group 2: Regulatory Environment - Recent regulatory changes have established actionable assessment standards for the proportion and stability of large state-owned insurance companies' investments in A-shares, promoting a long-term assessment mechanism [3]. - Adjustments to solvency rules have reduced the risk factors associated with stock investments, encouraging insurance capital to increase market participation [3]. Group 3: Equity Asset Allocation - The proportion of equity assets in insurance companies is gradually increasing, with equity investments accounting for approximately 20.6% of total investment assets as of the first quarter of this year [4]. - Regulatory guidelines dictate that the equity asset balance must not exceed certain thresholds based on the solvency ratio, allowing for a structured approach to equity investment [4]. Group 4: Future Outlook - Analysts believe that there is still considerable room for insurance companies to increase their equity asset allocation, as many companies are currently below their investment limits [5]. - The current capital market environment and accounting standards suggest that insurance capital is likely to continue expanding its equity asset holdings in the future [5].

Core Insights - The recent approval of China Taiping's private equity securities investment fund company marks a significant development in the long-term investment reform pilot for insurance capital, with the total number of insurance-related private equity fund management companies reaching six and over 200 billion yuan of "long money" flowing into the capital market [1][3][4] Group 1: Long-term Investment Reform - The establishment of private equity securities fund management companies by insurance firms is reshaping the capital market ecosystem, providing short-term stability and long-term support for economic transformation [1][3] - The pilot program for long-term investment reform initiated in October 2023 has seen a continuous expansion, with regulatory bodies approving multiple institutions to participate [3][4] - The total scale of the three batches of pilot programs has reached 222 billion yuan, indicating a significant injection of long-term funds into the market [4][7] Group 2: Investment Strategies and Focus - Insurance capital is expected to target key industries that are crucial for national interests, focusing on companies with competitive advantages and sound governance structures for long-term investments [5][6] - The "Honghu Fund," backed by China Life and New China Life, aims to invest in high-quality, stable dividend-paying blue-chip stocks, thereby reducing the impact of short-term market fluctuations on insurance companies' financial statements [6][7] - The establishment of insurance-related private equity fund management companies is anticipated to create new profit growth points for insurance capital, enhancing their competitiveness and influence in the market [7][8]

2022年6月，汇丰人寿完成股权变更，正式成为汇丰保险在中国内地的全资控股子公司。此后，作 为汇丰人寿的唯一股东，汇丰保险分别于2022年10月、2023年6月、2025年7月三度向汇丰人寿注资，使 其注册资本由10.25亿元逐步提升至16.6亿元、23.14亿元、26.76亿元。 汇丰人寿相关负责人表示，这体现了公司股东对于汇丰人寿在中国市场长期、健康、稳定发展的坚 定支持，并将进一步提高公司的偿付能力水平，增强公司抵御风险的能力。 业绩方面，汇丰人寿的盈利能力一直处于波动状态。2020年，该公司实现微薄盈利65.60万元。此 后三年，汇丰人寿分别亏损2.25亿元、5.41亿元、0.85亿元。直到2024年，汇丰人寿成功扭亏为盈，实 现净利润1.95亿元。 2025年上半年，汇丰人寿实现保险业务收入73.86亿元，同比增长8.5%；净亏损0.91亿元，与去年 同期盈利0.70亿元相比有明显下滑；截至二季度末，公司核心、综合偿付能力充足率分别为161.20%、 224.14%。 从履历来看，程思韵毕业于伦敦政治经济学院，获精算科学理学士学位，同时为英国精算师协会会 员，在精算咨询、保险、再保险等行业有超过二十 ...

Core Viewpoint - The introduction of drone postal routes in Shiban Rock Town significantly enhances logistics efficiency, connecting remote villages and transforming the delivery landscape in mountainous regions [1][3]. Group 1: Drone Postal Routes - The first regular drone postal route in Henan Province allows for delivery times to be reduced from one hour by car to just seven minutes by drone [1][3]. - Currently, there are 11 operational drone routes that link 11 remote mountain villages, with each drone capable of carrying 50 kilograms and making 1-2 trips daily [3]. Group 2: Historical Context - Historically, the region relied on manual transportation methods, such as carrying goods with a shoulder pole, which could take up to four hours to reach the town [2]. Group 3: Insurance and Risk Management - The development of drone logistics is supported by insurance products that cover risks associated with drone operations, including comprehensive coverage for drone damage and third-party liability, with a risk coverage amount exceeding 9.6 million yuan [3][4]. - The insurance sector is actively developing tailored insurance solutions for low-altitude economic activities, addressing various risks such as professional negligence and quality defects [4]. Group 4: Broader Economic Implications - The low-altitude economy, which includes drone logistics, is recognized as a strategic emerging industry in China's 14th Five-Year Plan, integrating advanced technologies to enhance productivity [4]. - The insurance company has insured over 150,000 drones, providing risk coverage exceeding 90 billion yuan, thereby facilitating the growth of the low-altitude economy [5].

Core Viewpoint - Insurance companies are actively increasing their stakes in listed companies, with Li'an Life Insurance recently raising its holdings in Jiangnan Water to 5.03%, triggering a stake increase notification [1][2]. Group 1: Insurance Companies' Actions - Li'an Life Insurance has made 18 stake increases in the market this year, indicating a strong interest in equity investments [1]. - The recent stake increase by Li'an Life is based on its own asset allocation needs and the perceived value of Jiangnan Water, funded by its own capital [2]. - Longcheng Life Insurance also increased its stake in Jiangnan Water, reaching 6.38% by March 2024, and has indicated potential for further increases [3]. Group 2: Market Trends and Preferences - The insurance sector is expected to continue increasing investments in companies with high dividends, capital appreciation potential, and high return on equity (ROE) [1][3]. - The infrastructure sector is particularly appealing to insurance companies due to its stable operating performance, cash flow, low valuations, and high dividend characteristics [4]. Group 3: Company Performance and Strategy - Jiangnan Water reported a revenue of 1.533 billion yuan for 2024, a year-on-year increase of 12.39%, and a net profit of 402 million yuan, up 24.31% [2]. - Li'an Life Insurance is undergoing a strategic transformation, aiming to become a mainstream financial institution in Jiangsu Province by 2030, with specific revenue and profit targets set for 2025 [7]. - In the first quarter of this year, Li'an Life achieved insurance business revenue of 12.545 billion yuan, a slight decrease of 4.2%, but net profit increased by 54.9% [7].

（原标题：尼泊尔保险业深陷"精算师荒" 每年数千万卢比外汇流失海外） 尽管《2022年保险法》强制要求年度精算评估，尼泊尔至今没有本土持证精算 师，导致保险业每年需花费数千万卢比聘请外国专家。目前，尼泊尔保险公司 完全依赖印度、斯里兰卡等国的精算服务。业内人士透露，这不仅造成高昂费 用和数月延误，还导致核心保险数据跨境传输的安全隐患。报道指出，虽然特 里布文大学已开设精算课程，但培养合格人才仍需至少5年。专家警告，若不 尽快建立本土人才培养机制，尼泊尔保险业将长期受制于人，影响行业发展。 ...

Core Viewpoint - The accessibility of innovative drugs and medical devices is crucial for patient health and the pharmaceutical industry's innovation development. Recent measures from Shanghai's financial regulatory authorities aim to enhance the role of commercial health insurance in this sector [1][4]. Group 1: Policy Measures - The Shanghai Financial Regulatory Bureau and seven other departments released 18 specific measures to promote the high-quality development of commercial health insurance, focusing on collaboration between basic medical insurance and commercial insurance [1][5]. - The measures clarify responsibilities among various departments and aim to quickly implement policies that will enhance the multi-layered medical security system [1][4]. Group 2: Market Dynamics - The innovative drug industry in China is experiencing rapid growth, with 43 innovative drugs approved in the first half of 2025, a 59% increase year-on-year [2]. - The current payment system for high-priced drugs shows structural deficiencies, with personal out-of-pocket expenses remaining high due to limited coverage from basic medical insurance [2][3]. Group 3: Role of Commercial Health Insurance - Commercial health insurance is identified as a key player in filling the payment gap for high-priced innovative drugs, providing more predictable payment solutions compared to charity or mutual aid [3][6]. - The growth of commercial health insurance premiums, which reached 622.3 billion yuan in the first half of 2025, indicates a growing market potential [2]. Group 4: Data Sharing and Product Innovation - The measures emphasize the importance of data sharing between medical institutions and insurance companies to enhance pricing accuracy and efficiency [8]. - Encouragement for the development of diverse health insurance products that cover innovative drugs is highlighted, aiming to meet the needs of different demographics [7][8]. Group 5: Future Outlook - The ongoing policy support and product innovation are expected to significantly enhance the role of commercial health insurance in improving the accessibility of innovative drugs [6][8]. - The collaboration between medical, insurance, and pharmaceutical sectors is anticipated to create a win-win situation, fostering a more robust multi-payment system for innovative drugs [6][7].

盛夏时节，在湖州市长兴县的纺织车间里，一台台新上线的节能设备正高速运转，这些设备的背 后，是"转型贷款+ESG保险"创新模式在支撑。作为当地支柱产业，长兴纺织业长期受困于高能耗、高 污染的发展瓶颈，2000余家市场经营主体的转型需求迫切。 据人保财险安吉支公司相关人士介绍，安吉白茶气象指数保险的独特之处在于，其以客观气象数据 为理赔依据，彻底改变了传统农业保险定损难、周期长的痛点。在县政府公布的白茶开采日前10天至开 采后21天内，只要气象站点监测到当日最低气温跌破0.5℃，理赔程序自动触发，实现"精准滴灌"，让 保险真正成为茶农抵御自然风险的"及时雨"。 "以前想更新设备却怕资金链断裂，现在有了保险托底，敢放心投入了。"长兴国圆印染有限公司负 责人邵云舟的感慨道出了众多企业的心声。据介绍，得益于人保财险长兴支公司为该企业投保的6870万 元ESG保险，企业获得信用背书，不仅碳效等级从4级提升至3级，从银行获取的贷款额度也从500万元 增至1000万元，贷款利率还降低了20个基点，让企业在设备更新的关键期获得了"粮草"补充。 2025年，安吉白茶气象指数低温保险累计承保面积8145.6亩，覆盖了全县12个乡镇 ...

Core Viewpoint - China Ping An has ceased disclosing monthly premium income data starting this year, citing that the new standards do not allow for a complete reflection of insurance service income, particularly for life insurance companies. The company emphasizes focusing on value indicators rather than scale indicators, as short-term data may not be valuable for investors [2]. Group 1 - China Ping An's last disclosed premium income announcement was on January 14, 2025, reporting the original insurance contract premium income for the entire year of 2024 [2]. - Other listed insurance companies, including China Life and China Pacific Insurance, have also stopped disclosing monthly premium income data this year, indicating a broader trend in the industry [2]. - In contrast, Xinhua Insurance and China Taiping still continue to disclose relevant monthly premium income data [2].

证券代码：601628 证券简称：中国人寿 编号：临2025－024 中国人寿保险股份有限公司 关于董事任职资格获金融监管总局核准的公告 重要提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 中国人寿保险股份有限公司（"本公司"）于2024年6月27日召开2023年年度股东大会，选举牛凯龙先生 为本公司第八届董事会非执行董事。 本公司近日收到国家金融监督管理总局（"金融监管总局"）关于牛凯龙任职资格的批复。根据该批复， 金融监管总局已核准牛凯龙先生担任本公司董事的任职资格，其任职自2025年8月6日起生效。自同日 起，牛凯龙先生担任本公司第八届董事会战略与资产负债管理委员会委员。 牛凯龙先生的简历请见本公司于2024年5月22日在上海证券交易所网站（www.sse.com.cn）发布的《中 国人寿保险股份有限公司2023年年度股东大会会议资料》。 特此公告 中国人寿保险股份有限公司 董事会 2025年8月12日 ...